KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,678,000 | -41.7% | 125,000 | -58.3% | 1.10% | -41.2% |
Q4 2017 | $2,880,000 | -67.2% | 300,000 | -62.5% | 1.88% | -22.5% |
Q3 2017 | $8,784,000 | +223.5% | 800,000 | +166.7% | 2.42% | +57.8% |
Q2 2017 | $2,715,000 | -23.1% | 300,000 | +9.1% | 1.54% | -12.1% |
Q1 2017 | $3,531,000 | – | 275,000 | – | 1.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |